Dendritic cells in MDS and AML – cause, effect or solution to the immune pathogenesis of disease?-Reference-Cited by-同舟云学术

Dendritic cells in MDS and AML – cause, effect or solution to the immune pathogenesis of disease?

Published:2005-01-27 Issue:3 Volume:19 Page:354-357
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Panoskaltsis N

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403634.pdf

Reference42 articles.

1. Ma L, Delforge M, Van Duppen V, Verhowef G, Emanuel B, Boogaerts M et al. Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes. Leukemia 2004; 18: 1451–1456.

2. Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Briere F, de Lamballeri X et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001; 98: 3750–3756.

3. Robinson SP, English N, Jaju R, Kearney L, Knight SC, Reid CDL . The in-vitro generation of dendritic cells from blast cells in acute leukaemia. Br J Haematol 1998; 103: 763–771.

4. Panoskaltsis N, Belanger TJ, Liesveld JL, Abboud CN . Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leuk Res 2002; 26: 191–201.

5. Harrison BD, Adams JA, Brigs M, Brereton ML, Liu Yin JA . Stimulation of autologous proliferative and cytotoxic T-cell responses by ‘leukemic dendritic cells’ derived from blast cells in acute myeloid leukemia. Blood 2001; 97: 2764–2771.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia;Blood Science;2021-10

2. Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis;PeerJ;2020-06-25

3. Tissue engineered models of healthy and malignant human bone marrow;Advanced Drug Delivery Reviews;2019-02

4. Chemotherapy Drug Scheduling for the Induction Treatment of Patients With Acute Myeloid Leukemia;IEEE Transactions on Biomedical Engineering;2014-07

5. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition;Leukemia;2014-02-07